A delegation from Houston consisting of former astronauts, aircraft experts, and local leaders were invited to the Paris Air Show to represent the Space City. Photo courtesy of the Greater Houston Partnership

Houston takes flight at Paris Air Show just in time for Space City Month​

Oui, oui

As we move closer to the 50th anniversary of Apollo 11 in mid-July, eyes around the world are turning to the United States and to Houston's NASA Johnson Space Center in celebration of the historic mission that first brought mankind to the moon. Thanks to that unprecedented interest, Houston was asked to be a featured partner of the USA Partnership Pavilion at the Paris Air Show last month.

Drawing nearly 2,500 exhibitors from 49 countries and more than 316,000 total visitors, the Paris Air Show continues to be the world's premier aerospace and aviation industry event. Houston's historic achievements set the stage to showcase how the region continues to be a global hub for technology and innovation.

A delegation of top Houston organizations brought distinct assets that showcased a collective advantage in competing for aerospace business. Led by the Greater Houston Partnership under the promotional banner Space City: The Gateway to Innovation, the group included:

  • Houston Spaceport, one of the nation's 10 licensed commercial spaceports co-located at Ellington Field (EFD).
  • Rice Space Institute, which has helped to establish Rice University's international reputation in all areas of space research by investing in efforts to further the development of new ideas and innovation in the broad area that is space exploration and utilization.
  • SpaceCom, the Space Commerce Conference and Exposition, an annual two-day conference that connects NASA technology with the private sector to fuel future innovation
  • Space Center Houston, the official visitor center of NASA's Johnson Space Center and a leading science and space learning center.
  • Blue Bear Capital, a Houston-based venture capital firm investing in fast-growing private companies that apply data driven technologies and innovative business models to the global energy supply chain.
  • Trumbull Unmanned, A Forbes Top 25 Veteran Founded startup based out of the Houston Spaceport that collects, analyzes, and visualizes critical data for the energy sector, primarily supporting oil and gas and environmental efforts.

As an anchor NASA community and home to the sharpest minds in aerospace, life sciences, energy and innovation, it was only fitting that Houston have a prominent presence in the show at Le Bourget. Among the 300 exhibitors representing the United States in the USA Partnership Pavilion, twenty of which were states, Houston was the only city with a major presence. Throughout the week, the Houston delegation participated in a schedule of high-profile thought-leadership and hospitality events to engage and educate global industry and government decision-makers and influencers.

For our part at the Greater Houston Partnership, we were able to conduct a series of meetings with companies from around the world, gathering more than 40 international and domestic economic development leads. The show is also a great media opportunity that allowed us to secure nearly 20 interviews for our delegation members with print and broadcast outlets from across the U.S. and Europe.

The USA Partnership Pavilion's week-long celebration of innovation and human achievement was led Apollo Astronauts Brig. Gen. Charlie Duke, and Houston-natives Col. Walt Cunningham and Col. Al Warden. Their presence served as a tangible way to connect our nation's achievements to the innovative future of the global aerospace industry.

"The 50th anniversary is such a unique time in history. It gives us an opportunity to think back about what we did, realize where we are today, and where we want to be in the future," says Col. Al Worden, "The most important thing about the space program was not so much about putting a man on the moon, it was about developing the technology to get there. Those technologies have made this country so successful, and I hope we continue to see that type of commitment to technology development in the future."

Houston delegates were asked to participate in several thought leadership panels.

"As we continue to explore further into the universe, there are a myriad of technical challenges that need to be overcome," says David Alexander, director of Rice Space Institute, who moderated a panel discussion on advancing technologies that will help humans physically and mentally adapt to deep space exploration. He was joined by industry leaders from United Launch Alliance (ULA), Lockheed Martin, Virgin Galactic, and Harris Corporation for the conversation centered around the use of artificial intelligence, 3D printing and additive manufacturing.

Governments around the globe including those in Europe, China and of course the United States have accelerated a discussion about sending humans back to the moon as a key step in our continued human exploration of deep space. This concept is also proving attractive to private companies, with an increase in public-private partnerships and a broader role being played by commercial entities in government aspirations.

Former astronaut and Space Station Commander turned venture capital leader Tim Kopra participated in a panel discussion on this very topic alongside representative from United Launch Alliance (ULA), the Federal Aviation Administration (FAA), Lockheed Martin, Deloitte, and the U.S. Air Force. Although Kopra's Blue Bear Capital's primary target are data-driven technologies in the energy industry, he notes that "there are a lot of intersections between energy and aerospace, and Houston's melting pot of global industries has turned the region into a hot bed for innovation with broader application of technologies."

The centerpiece of the Houston delegation's presence at the Paris Air Show was an executive briefing on June 19 featuring keynote remarks from Kopra that helped set the tone for the work Houston continues to do in innovation and aerospace technology. Kopra discussed his background with NASA, the transition into the funding scene that supports the region's growing innovation ecosystem, and what Houston has to offer businesses looking to expand their operations in the areas of aerospace, manufacturing, and digital technology.

A panel discussion followed, addressing topics that included educating the next generation of engineers and explorers, the intersection of NASA technology and the private sector, the next frontier of space exploration and the unique position that Houston has in pioneering those efforts.

"Over the past 58 years, Johnson Space Center has led the U.S. and the world in human exploration, discovery, and achievement in space," Kopra tells the audience. "Now we are in a position of transitioning a lot of those capabilities into the civilian sector."

The Houston Spaceport is one big step in that ongoing evolution. As the only commercial spaceport in the nation centered in a large metropolitan area, the Houston facility will have unmatched access to resources for companies and operators, said Arturo Machuca, general manager of the spaceport.

"The Houston Spaceport is being developed to ensure Houston stays relevant in commercial aerospace and aviation activities," he says. "Houston continues to hold a strong value proposition for companies looking to enter the aerospace industry with a unique set of advantages including the proximity to NASA's Johnson Space Center, unparalleled infrastructure through the Houston Airport System, and a strong talent base."

------

Josh Davis is the director of International Investment and Trade at the Greater Houston Partnership and organized the Partnership's participation at the Paris Air Show and gathered the delegation.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston startup raises $6M to scale home-based healthcare platform

fresh funding

As healthcare systems race to expand care beyond hospitals and into the home, investors are placing bigger bets on the infrastructure needed to make that shift possible.

This month, Rosarium Health announced it has raised $6 million in seed funding led by Kalos Ventures, with participation from ResilienceVC, Rock Health Capital, Symphonic Capital, Black Tech Nations Ventures and others.

The investment will help the Houston-based startup continue to build its platform, which features a national network of 800-plus clinicians and 3,000-plus contractors to coordinate home accessibility upgrades and modifications for seniors and people living with disabilities.

For founder and CEO Cameron Carter, the company’s mission grew out of firsthand caregiving experiences.

“From my own personal caregiving experiences, I realized that the benefits exist on paper, but not in reality,” Carter said in a news release. “Families are being left to figure out the paperwork and installations all on their own, which shouldn’t be how this works.”

While Medicare Advantage and Medicaid plans have expanded coverage for home-based services and accessibility modifications, the logistics behind delivering those services often remain fragmented.

Rosarium’s platform coordinates the entire process, from clinical assessments and referrals to contractor management, documentation, reimbursement and installation.

“A clinician can document that a home isn’t safe and a plan can approve a benefit, but there’s no one that’s responsible for making sure the work actually gets done,” Carter says. “We built the missing piece.”

The company was founded in 2021 as Rose Health and was a 2023 participant in the Texas Medical Center’s Accelerator for HealthTech program. It has scaled quickly, building a network of more than 800 clinicians and 3,000 contractors across 34 states.

Rosarium is currently in-network for 1.2 million Medicare and Medicaid lives, with projected coverage expected to reach nearly 4 million by the end of the year, according to the release.

“We’re excited to back Cameron because he and the team at Rosarium are building the infrastructure healthcare needs right now to make the home a safe and comfortable place of care,” Kate Ballinger, investor at Kalos Ventures, added in the release.

As part of the recent investment, Ballinger will join Rosarium’s board of directors.

With eyes on the future, Rosarium plans to grow its partnerships with Medicaid and Medicare Advantage plans, including CalViva and Community Health Plan of Imperial Valley, strengthening its presence in California while expanding access to underserved communities.

Additionally, Carter predicts that home-based healthcare will be part of a broader transformation happening across the industry.

“There’s a growing recognition that health outcomes are shaped by what happens in the home,” he said in the release. “The future of healthcare isn’t just treating people after something goes wrong. It’s creating environments that help prevent those problems in the first place.”

Houston business mogul Tilman Fertitta acquires Caesars in $17.6B deal

Money Moves

Houston billionaire Tilman Fertitta may currently be serving as America’s ambassador to Italy, but his company is as busy as ever. Fresh off its move to revive the Houston Comets WNBA franchise, his company, Fertitta Entertainment, has announced a $17.6 billion deal to acquire Caesars Entertainment, Inc.

Speculation about the deal has been circulating since at least March, according to various media reports. The deal combines Fertitta’s well-known Golden Nugget casino brand with all of the properties in the Caesars’ portfolio, including Las Vegas hotels Caesars Palace, Harrah's, Paris Las Vegas, Planet Hollywood, Horseshoe, The LINQ Hotel, Flamingo, and The Cromwell.

Overall, the combined company will include 60 domestic casino resorts and gaming facilities; online gaming including sports betting, iCasino, and Caesar’s online poker platform; retail sports betting at over 200 third-party locations through the William Hill brand; and over 550 Fertitta Entertainment outlets, including more than 450 Landry's full-service restaurants across America. The companies will combine their loyalty programs, Caesars Rewards, Golden Nugget's 24 Karat Select Club, and Landry's Select Club.

The terms will see Caesars’ shareholders receive $31 per share. Fertitta Entertainment will also acquire approximately $11.9 billion of Caesars' outstanding debt.

The transaction will be financed through a combination of equity contributed by Fertitta Entertainment, assumed Caesars' debt, and new committed debt financing arranged by a group consisting of 10 banks. It is subject to approval by Caesars’ shareholders and government regulators.

Fertitta Entertainment is the Houston-based company behind a diverse array of hospitality businesses, including The Golden Nugget, The Post Oak Hotel, River Oaks District, the Kemah Boardwalk, and Houston’s Downtown Aquarium.

It also operates a number of prominent restaurant brands, including Mastro's Restaurants, Del Frisco's Double Eagle Steakhouse, Morton's The Steakhouse, The Palm, McCormick & Schmick's, Landry's Seafood House, The Oceanaire Seafood Room, and Saltgrass Steak House.

---

This article first appeared on CultureMap.com.

4 Houston-area institutions get $8M for cancer research facilities

fighting cancer

Cancer research capabilities in the Houston area just got an $8 million boost.

On Wednesday, May 20, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded $8 million in grants to institutions in Houston and Bryan for the creation or expansion of so-called “core” cancer research facilities.

“Core facilities provide shared access to advanced technology, equipment, and scientific expertise that may not be available at every institution,” CPRIT says. “These core facilities are vital to not only cancer research but also to the study of diseases beyond cancer.”

Houston-area recipients of these $2 million grants are:

  • A facility at the University of Texas Health Science Center for preclinical support of cancer researchers in Texas to evaluate new safe, effective drugs and drug combinations.
  • The Accelerator for Cancer Therapeutics, operated by Houston’s Texas Medical Center Foundation. The accelerator helps researchers and startups move innovative cancer treatments from the lab to clinical trials.
  • Rice University’s Genetic Design & Engineering Center in Houston. The center enables researchers to collaborate on studies of custom DNA for cancer treatment.
  • A facility at the Texas A&M University System’s Health Science Center in Bryan that aims to speed up the development of cancer therapies.

In addition to those grants, the University of Texas M.D. Anderson Cancer Center, Methodist Hospital Research Institute, Baylor College of Medicine, and Rice University shared $21 million to recruit cancer researchers from other institutions.

The largest of those grants—totalling $4 million—went to M.D. Anderson for the recruitment of renowned cancer researcher Andre Nussenzweig from the National Institutes of Health. His research focuses on how DNA damage and faulty DNA repairs lead to cancer.

Here are the totals for the other CPRIT grants awarded in the Houston area:

  • $12.8 million to Houston-based Indapta Therapeutics for the development of an off-the-shelf therapy that naturally kills cancer cells, combined with an immunity-targeting agent for a type of leukemia.
  • $11.1 million to MD Anderson, including $5 million for a statewide platform to improve long-term health outcomes in adolescents and young adults who survived cancer.
  • $8.4 million to Baylor College of Medicine, including $4.8 million for two training programs for cancer researchers.
  • $6.25 million to UT Health Houston, including $4 million for a biomedical informatics and genomics training program for cancer researchers.
  • $4.4 million to the Texas A&M Health Science Center’s Houston campus, including $2.4 million for a cancer therapeutics training program.
  • $2.75 million to Rice, including $250,000 for a study of ovarian cancer.
  • $2 million to Houston-based March Biosciences for the development of a targeted therapy for treating T-cell lymphoma.
  • $1.15 million to the University of Houston, including $900,000 for a platform for detection of lung cancer.
  • $900,000 to Texas A&M in Bryan to conduct clinical drug trials in rural and underserved communities around the state.
  • $800,000 to Houston- and Israel-based Xerient Pharma for the development of an oral form of a cell-protecting drug called amifostine to protect the upper GI tract from radiation damage during pancreatic cancer treatment.
  • $659,000 to Missouri City-based OmniNano Pharmaceuticals for the development of a two-drug combination to treat the most common form of pancreatic cancer.
  • $250,000 to the University of Texas Medical Branch at Galveston for a novel therapeutic to prevent colitis-related colorectal cancer.